Ohio § 4725.31 Clinically significant drug-induced side effects

Ohio Statutes

§ 4725.31 — Clinically significant drug-induced side effects

Ohio § 4725.31

Title 47Occupations-Professions

Ch. 4725Optometrists; Dispensing Opticians

This text of Ohio § 4725.31 (Clinically significant drug-induced side effects) is published on Counsel Stack Legal Research, covering Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Ohio Rev. Code Ann. § 4725.31 (2026).

Text

An optometrist licensed by the state vision professionals board shall promptly report to the board any instance of a clinically significant drug-induced side effect in a patient due to the optometrist's administering, employing, applying, or prescribing a topical ocular or therapeutic pharmaceutical agent to or for the patient. The board, by rule adopted in accordance with Chapter 119. of the Revised Code, shall establish reporting procedures and specify the types of side effects to be reported. The information provided to the board shall not include the name of or any identifying information about the patient.

Free access — add to your briefcase to read the full text and ask questions with AI

An optometrist licensed by the state vision professionals board shall promptly report to the board any instance of a clinically significant drug-induced side effect in a patient due to the optometrist's administering, employing, applying, or prescribing a topical ocular or therapeutic pharmaceutical agent to or for the patient. The board, by rule adopted in accordance with Chapter 119. of the Revised Code, shall establish reporting procedures and specify the types of side effects to be reported. The information provided to the board shall not include the name of or any identifying information about the patient.